Holen Sie sich die Stockscreener-App
17.95
1.81%
0.3189
Handel nachbörslich:
18.22
0.275
+1.53%
Schlusskurs vom Vortag:
$17.63
Offen:
$17.92
24-Stunden-Volumen:
1,071
Relative Volume:
0.27
Marktkapitalisierung:
$433.70M
Einnahmen:
$1.70M
Nettoeinkommen (Verlust:
$-47.01M
KGV:
-10.56
EPS:
-1.7
Netto-Cashflow:
$-157.28M
1W Leistung:
-2.23%
1M Leistung:
+11.60%
6M Leistung:
+7.61%
1J Leistung:
-11.86%
1-Tages-Spanne:
$17.92
$17.99
1-Wochen-Bereich:
$17.63
$18.51
52-Wochen-Spanne:
$13.30
$24.99
Puretech Health Plc Adr Stock (PRTC) Company Profile
Firmenname
Puretech Health Plc Adr
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie PRTC mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PRTC
Puretech Health Plc Adr
|
17.95 | 425.99M | 1.70M | -47.01M | -157.28M | -1.70 |
|
VRTX
Vertex Pharmaceuticals Inc
|
412.22 | 104.45B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
469.36 | 60.95B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.60 | 59.11B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
812.95 | 49.23B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.94 | 35.92B | 4.56B | -176.77M | 225.30M | -1.7177 |
Puretech Health Plc Adr Stock (PRTC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-09-09 | Fortgesetzt | Leerink Partners | Outperform |
Puretech Health Plc Adr Aktie (PRTC) Neueste Nachrichten
PureTech Health (NASDAQ:PRTC) Trading Up 3.6%Here's What Happened - MarketBeat
PureTech Health PLC Sponsored ADR (NASDAQ:PRTC) Sees Significant Growth in Short Interest - MarketBeat
PureTech Health (LON:PRTC) Shares Up 14.2% – Should You Buy? - Defense World
Parallel Advisors LLC Acquires 1,718 Shares of GSK PLC Sponsored ADR $GSK - Defense World
What Makes PureTech Health (PRTC) a New Buy Stock - Yahoo Finance
PureTech Health PLC Sponsored ADR (NASDAQ:PRTC) Sees Large Growth in Short Interest - MarketBeat
PureTech Health (NASDAQ:PRTC) Shares Up 4.7%Time to Buy? - MarketBeat
PureTech Health Cash Runway Extended - The Motley Fool
International Flavors & Fragrances (NYSE:IFF) & DAQO New Energy (NYSE:DQ) Critical Comparison - Defense World
Conference Calls and Individual Investors - MarketBeat
Deupirfenidone: A Potential New Standard of Care - Placera.se
PureTech advances deupirfenidone as potential new standard for IPF - Investing.com
PureTech Health to report half-yearly results on August 28 - Investing.com
PureTech Health to report half-yearly results on August 28 By Investing.com - Investing.com South Africa
PureTech Health (NASDAQ:PRTC) Trading Up 1.4% – Still a Buy? - Defense World
PureTech Health (NASDAQ:PRTC) Shares Down 7.3% – Here’s What Happened - Defense World
PureTech’s Seaport doses first patient in phase 2b depression study By Investing.com - Investing.com South Africa
PureTech Health names Robert Lyne as interim CEO as Chowrira departs - Investing.com
PureTech Health names Robert Lyne as interim CEO as Chowrira departs By Investing.com - Investing.com India
Big Oil's Q2 Outlook: Downstream Gains and Upstream Pains - The Globe and Mail
PureTech Health announces board leadership transition By Investing.com - Investing.com South Africa
PureTech Health announces board leadership transition - Investing.com
PureTech Health announces board chair Raju Kucherlapati steps down - Investing.com
PureTech Health issues shares to executives following RSU vesting - Investing.com
PureTech Health announces RSU vesting and share transactions by PDMR - Investing.com
PureTech Health issues shares to non-executive directors as RSUs vest - Investing.com
PureTech set for Jefferies Global Healthcare Conference chat By Investing.com - Investing.com India
PureTech set for Jefferies Global Healthcare Conference chat - Investing.com
PureTech’s Deupirfenidone (LYT-100) Demonstrates Strong and Durable Efficacy as a Monotherapy with Favorable Tolerability in Phase 2b ELEVATE IPF Trial - Placera.se
PureTech research reveals gaps in IPF patient care - Investing.com
PureTech research reveals gaps in IPF patient care By Investing.com - Investing.com South Africa
PureTech Health PLC (PTCHF) (FY 2024) Earnings Call Highlights: Strong Financial Execution and ... By GuruFocus - Investing.com Canada
PureTech Health to release annual financial results April 30 - Investing.com
PureTech Health to release annual financial results April 30 By Investing.com - Investing.com South Africa
PureTech Health enlists Peel Hunt as joint broker - Investing.com
Invesco Ltd: Form 8.3PureTech Health PLC; Opening Position disclosure - The Manila Times
PureTech Health in potential acquisition talks with Nordic Capital - Investing.com
Nordic Capital XI ends pursuit of PureTech acquisition - Investing.com
PureTech Health issues shares to executives after RSU vesting - Investing.com
PureTech set for fireside chat at global healthcare event - Investing.com
PureTech to present at J.P. Morgan Healthcare Conference By Investing.com - Investing.com India
Top Biotech Stocks: Exploring Innovation Opportunities - MarketBeat
PureTech Health: Launch of Proposed $100 Million Tender Offer at 250 Pence Per Ordinary Share - FinancialContent
symbol__ Stock Quote Price and Forecast - CNN
The definitive Boston biotech layoff tracker for 2023 - The Business Journals
Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time - MarketBeat
This Emerging Market Could Be The Next Big Thing In Biotech - Barchart.com
PureTech Share Price (PRTC) - London South East
Royalty Pharma and PureTech Health Enter KarXT Royalty Agreement for Up to $500M - Investing.com India
The Petri Dish: 1910 Genetics hires CBO; PureTech calls off merger - The Business Journals
Has Nextgen Healthcare (NXGN) Outpaced Other Medical Stocks This Year? - Nasdaq
Finanzdaten der Puretech Health Plc Adr-Aktie (PRTC)
Umsatz
Nettogewinn
Free Cashflow
ENV
5.15%
1.45%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):